GDF15 and diabetic kidney disease: For instance, FGF1 has been previously shown to inhibit the NF-κB pathway in experimental diabetic nephropathy [43], whereas GDF15–mediated inhibition of NF-κB signalling reduces infiltration of macrophages and arrests the pro-apoptotic activity in early tumour development [44].